2 hours ago TRESIBA ® is a long-acting basal insulin called insulin degludec. It is used to treat diabetes mellitus in adults, adolescents and children aged 1 year and above. TRESIBA ® can be used with meal-related rapid-acting insulin products. In type 2 diabetes mellitus, TRESIBA ® may be used in combination with tablets for diabetes or with injectable antidiabetic medicines, other than insulin >> Go To The Portal
To receive the offer, prescription must be for a 1-month or 3-month supply. See Tresiba ® Important Safety Information > View Tresiba ® Prescribing Information > Patients may be eligible for the following: Direct patients to visit TresibaSavings.com to activate, request, or print their savings card. a Eligibility and other restrictions apply.
Tresiba ® (insulin degludec injection) is indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus. Tresiba ® is not recommended for treating diabetic ketoacidosis.
Adjustments in concomitant anti-diabetic treatment may be needed. Hypoglycemia is the most common adverse reaction of insulin, including Tresiba ®, and may be life-threatening.
The 8-digit DIN (Drug Identification Number) is printed on the Tresiba®package and pen, and may be on the receipt your pharmacist gave you.
Before taking Tresiba®, tell your health care provider about all your medical conditions, including if you are: pregnant, planning to become pregnant, or are breastfeeding. taking new prescription or over-the-counter medicines, vitamins, or herbal supplements.
If children miss a dose of Tresiba ®: Call the healthcare provider for information and instructions about checking blood sugar levels more often until the next scheduled dose of Tresiba ®. For children who need less than 5 units of Tresiba ® each day, use a Tresiba ® U-100 vial. Check your blood sugar levels.
Make sure there are at least 8 hours between doses.
You may give them a serious infection, or get a serious infection from them. Never inject Tresiba ® into a vein or muscle.
Prescription Tresiba ® is a long-acting insulin used to control high blood sugar in adults and children who are 1 year of age and older with diabetes. Tresiba ® is not for people with diabetic ketoacidosis. It is not known if Tresiba ® is safe and effective in children under 1 year of age. Tresiba ® is available in 2 concentrations: 200 units/mL ...
Novo Nordisk is committed to your success with Tresiba®. That's why we give you resources to help you follow your care plan. In addition to information about Tresiba®, you'll have access to all the diabetes management resources available through our support program at Cornerstones4Care.com.
Tresiba ® Selected Important Safety Information. Do not share your Tresiba® FlexTouch® with other people, even if the needle has been changed. Do not share needles or syringes with another person. You may give other people a serious infection, or get a serious infection from them.
Before taking Tresiba®, tell your health care provider about all your medical conditions, including if you are: pregnant, planning to become pregnant, or are breastfeeding. taking new prescription or over-the-counter medicines, vitamins, or herbal supplements. Talk to your health care provider about low blood sugar and how to manage it.
For children who need less than 5 unit s of Tresiba ® each day, use a Tresiba ® U-100 vial. Check your blood sugar levels. Ask your health care provider what your blood sugar levels should be and when you should check them. Do not reuse or share your needles or syringes with other people.
Make sure there are at least 8 hours between doses.
Do not share your Tresiba® FlexTouch® with other people, even if the needle has been changed. Do not share needles or syringes with another person. You may give other people a serious infection, or get a serious infection from them.
Tresiba ® is not for people with diabetic ketoacidosis. It is not known if Tresiba ® is safe and effective in children under 1 year of age.
For children who need less than 5 unit s of Tresiba ® each day, use a Tresiba ® U-100 vial. Check your blood sugar levels. Ask your health care provider what your blood sugar levels should be and when you should check them. Do not reuse or share your needles or syringes with other people.
Make sure there are at least 8 hours between doses.
Tresiba ® is not for people with diabetic ketoacidosis. It is not known if Tresiba ® is safe and effective in children under 1 year of age. Tresiba ® is available in 2 concentrations: 200 units/mL and 100 units/mL.
is here to help. Prescription Tresiba ® is a long-acting insulin used to control high blood sugar in adults and children who are 1 year of age and older with diabetes.
Do not share your Tresiba® FlexTouch® with other people, even if the needle has been changed. Do not share needles or syringes with another person. You may give other people a serious infection, or get a serious infection from them.
Do not take Tresiba® if you: are having an episode of low blood sugar. are allergic to Tresiba ® or any of the ingredients in Tresiba ®. Before taking Tresiba®, tell your health care provider about all your medical conditions, including if you are: pregnant, planning to become pregnant, or are breastfeeding.
Tresiba contains insulin degludec, an ultra-long acting insulin that starts to work 60 minutes after administration and keeps working for up to 42 hours. Tresiba is approved for use in adults and children over the age of one with type 1 or type 2 diabetes.
Common medications that may interact with Tresiba include: antibiotics, such as doxycycline and minocycline. antidepressants such as SSRIs (eg, fluoxetine, sertraline), monoamine oxidase inhibitors (MAOI) such as selegiline, isocarboxazid, and phenelzine. antiepileptics, such as fosphenytoin and phenytoin.
Tresiba is made using genetic engineering technology. Although it resembles human insulin in most of its structure, the amino acid threonine in position B30 has been replaced by a side chain containing glutamine and a C16 fatty acid. Tresiba exists as stable insulin dihexamers bonded by zinc.
Tresiba is less likely than insulin glargine to cause severe hypoglycemia. 7. Interactions. Medicines that interact with Tresiba may either decrease its effect, affect how long it works for, increase side effects, or have less of an effect when taken with Tresiba.
The dosage of Tresiba may need to be reduced in liver or kidney disease. Blood glucose levels should be carefully monitored in people with these conditions. Seniors may be more susceptible to the side effects of ultra long-acting insulins, such as insulin degludec.
Tresiba exists as stable insulin dihexamers bonded by zinc. Once Tresiba is injected, the insulin dihexamers form multihexamers. The rate of insulin absorption depends on the size of the insulin molecules, so these large insulin hexamers stay in place, creating an insulin depot (storage).
Tresiba is available in two concentrations U-100 and U-200. No dose conversion is necessary when switching from the U-100 to the U-200 pen as the dose window shows the number of insulin units to be delivered and no conversion is needed.